Envestnet Asset Management’s Hepion Pharmaceuticals HEPA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-157
| Closed | -$122K | – | 4010 |
|
2023
Q1 | $122K | Sell |
157
-46
| -23% | -$35.7K | ﹤0.01% | 3768 |
|
2022
Q4 | $61K | Buy |
203
+115
| +131% | +$34.5K | ﹤0.01% | 3854 |
|
2022
Q3 | $44K | Buy |
88
+28
| +47% | +$14K | ﹤0.01% | 3817 |
|
2022
Q2 | $34K | Buy |
60
+2
| +3% | +$1.13K | ﹤0.01% | 3850 |
|
2022
Q1 | $75K | Sell |
58
-14
| -19% | -$18.1K | ﹤0.01% | 3831 |
|
2021
Q4 | $82K | Buy |
72
+34
| +89% | +$38.7K | ﹤0.01% | 3778 |
|
2021
Q3 | $59K | Sell |
38
-55
| -59% | -$85.4K | ﹤0.01% | 3623 |
|
2021
Q2 | $184K | Buy |
93
+67
| +258% | +$133K | ﹤0.01% | 3507 |
|
2021
Q1 | $48K | Buy |
+26
| New | +$48K | ﹤0.01% | 3451 |
|